Biological Characteristics of Thyroid Carcinomas

Jin-Woo Park

doi:10.5124/jkma.2004.47.12.1144

Journal List > J Korean Med Assoc > v.47(12) > 1080333

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Park: Biological Characteristics of Thyroid Carcinomas

Special Issue

Thyroid Cancer

Journal of the Korean Medical Association

Journal of the Korean Medical Association 2004; 47(12): 1144-1151.

Published online: 31 December 2004

DOI: https://doi.org/10.5124/jkma.2004.47.12.1144

Biological Characteristics of Thyroid Carcinomas

Jin-Woo Park, M.D.

Department of Surgery, Chungbuk National University, College of Medicine & Hospital, Korea. webjwpark@chungbuk.ac.kr

Abstract

Thyroid carcinomas show a broad spectrum of neoplastic phenotypes with distinct molecular events. In a thyroid multistep tumorigenesis model for differentiated thyroid carcinomas of follicular cell origin(DTCs), normal thyrocytes are transformed to differentiated thyroid cancer and progress to poorly differentiated thyroid carcinomas(PDTCs) and ultimately anaplastic thyroid carcinomas(ATCs), through the progressive accumulation of alterations in genes related with cell proliferation and differentiation. PDTCs and ATCs lose expression of thyroid-specific genes such as thyroglobulin, TSH-R, sodium/iodide symporter(NIS) genes and thyroid specific transcription factors. These tumors unfortunately may grow rapidly, invade adjacent structures and spread to other parts of the body. Biological characteristics of thyroid carcinomas are also quite different according to histological types. Most of DTCs show favorable biological behavior and keep their differentiated functions such as iodine uptake and TSH responsiveness. Unlike the other human carcinomas, presence of regional lymph node metastasis does not alter outcome significantly but age at diagnosis profoundly affect biological behavior of DTCs. Many cases of ATCs appear to be associated with preexisting DTC and p53 mutation plays an important role in this terminal dedifferentiation. ATC is highly aggressive and lethal. Medullary thyroid carcinomas(MTCs) originate from calcitonin secreting C cell by point mutation of ret protooncogene. Some specific ret mutations(genotypes) predict the phenotypic expression of hereditary MTC, guiding the timing of thyroidectomy. Understanding of biological characteristics and behavior of thyroid carcinomas help us to make a logical decision for optimal timing and extent of surgical treatment and postoperative adjuvant therapy.

Keywords: Multistep tumorigenesis model, Dedifferentiation, Histological type, Age at diagnosis, Genotype

References

1. Farid NR, Shi Y, Zou M. Moecular basis of thyroid cancer. Endocr Rev. 1994. 15:202–232.

2. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, et al. PAX8-PPAR gamma1 fusion in oncogene human thyroid carcinoma. Science. 2000. 289:1357–1360.

3. Wada N, Duh QY, Miura D, Brunaud L, Wong MG, Clark OH. Chromosomal aberrations by comparative genomic hybridization in Hürthle cell thyroid carcinomas are associated with tumor recurrence. J Clin Endocrinol Metab. 2002. 87:4595–4601.

4. Erickson LA, Jalal SM, Goellner JR, Law ME, Harwood A, Jin L, et al. Analysis of Hürthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization. Am J Surg Pathol. 2001. 25:911–917.

5. Jossart GH, Epstein HD, Shaver JK, Weier HU, Greulich KM, Tezelman S, et al. Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines. J Clin Endocrinol Metab. 1996. 81:3498–3504.

6. Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, et al. Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res. 2001. 08. 15. 61:6105–6111.

7. Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M, et al. Surgical reintervention for differentiated thyroid cancer. Br J Surg. 1993. 80:1009–1012.

8. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer. 1983. 52:1849–1855.

9. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985~1995. Cancer. 1998. 83:2638–2648.

10. Ros P, Rossi DL, Acebron A, Santisteban P. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Biochimie. 1999. 81:389–396.

11. Zielke A, Hoffmann S, Plaul U, Duh QY, Clark OH, Rothmund M. Pleiotropic effects of thyroid stimulating hormone in a differentiated thyroid cancer cell line. Studies on proliferation, thyroglobulin secretion, adhesion, migration and invasion. Exp Clin Endocrinol Diabetes. 1999. 107:361–369.

12. Sagartz JE, Jhiang SM, Tong Q, Capen CC. Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogene. Lab Invest. 1997. 76:307–318.

13. Kimura H, Yamashita S, Namba H, Usa T, Fujiyama K, Tsuruta M, et al. Impairment of the TSH signal transduction system in human thyroid carcinoma cells. Exp Cell Res. 1992. 203:402–406.

14. Sywak M, Pasieka JL, Ogilvie T. A review of thyroid cancer with intermediate differentiation. J Surg Oncol. 2004. 04. 01. 86:44–54.

15. Park JW, Clark OH. Redifferentiation therapy for thyroid cancer. Surg Clin North Am. 2004. 06. 84:921–943.

16. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985~1995. Cancer. 1998. 12. 15. 83:2638–2648.

17. LiVolsi VA. LiVolsi VA, editor. Papillary lesions of the thyroid. Surgical pathology of the thyroid. 1990. Philadelphia: W.B. Saunders Company;136–172.

18. Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab. 1998. 11. 83:4116–4122.

19. Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg. 1996. 12. 172:692–694.

20. Noguchi M, Kinami S, Kinoshita K, Kitagawa H, Thomas M, Miyazaki I, et al. Risk of bilateral cervical lymph node metastases in papillary thyroid cancer. J Surg Oncol. 1993. 07. 52:155–159.

21. Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg. 1978. 07. 136:107–112.

22. Hung CJ, Ginzinger DG, Zarnegar R, Kanauchi H, Wong MG, Kebebew E, et al. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J Clin Endocrinol Metab. 2003. 08. 88:3694–3699.

23. Hwang JH, Hwang JH, Chung HK, Kim DW, Hwang ES, Suh JM, et al. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells. J Clin Endocrinol Metab. 2003. 01. 88:408–416.

24. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer. 1990. 07. 15. 66:321–330.

25. Shvero J, Gal R, Avidor I, Hadar T, Kessler E. Anaplastic thyroid carcinoma. A clinical, histologic, and immunohistochemical study. Cancer. 1988. 07. 15. 62:319–325.

26. Khurana KK, Labrador E, Izquierdo R, Mesonero CE, Pisharodi LR. The role of fine-needle aspiration biopsy in the management of thyroid nodules in children, adolescents, and young adults : a multi-institutional study. Thyroid. 1999. 04. 9:383–386.

27. Hung W. Solitary thyroid nodules in 93 children and adolescents. a 35-years experience. Horm Res. 1999. 52:15–18.

28. Tronko MD, Bogdanova TI, Komissarenko IV, Epstein OV, Oliynyk V, Kovalenko A, et al. Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident : statistical data and clinicomorphologic characteristics. Cancer. 1999. 07. 01. 86:149–156.

29. Vassilopoulou-Sellin R, Goepfert H, Raney B, Schultz PN. Differentiated thyroid cancer in children and adolescents : clinical outcome and mortality after long-term follow-up. Head Neck. 1998. 09. 20:549–555.

30. Harness JK, Thompson NW, McLeod MK, Pasieka JL, Fukuuchi A. Differentiated thyroid carcinoma in children and adolescents. World J Surg. 1992. 07-08. 16:547–553. discussion 553-4.

31. Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med. 1998. 09. 39:1531–1536.

32. Coburn MC, Wanebo HJ. Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg. 1995. 11. 170:471–475.

33. Cady B. Presidential address : beyond risk groups-a new look at differentiated thyroid cancer. Surgery. 1998. 12. 124:947–957.

34. Vini L, Hyer SL, Marshall J, A'Hern R, Harmer C. Long-term results in elderly patients with differentiated thyroid carcinoma. Cancer. 2003. 07. 01. 97:2736–2742.

35. Santoro M, Thomas GA, Vecchio G, Williams GH, Fusco A, Chiappetta G, et al. Gene rearrangement and Chernobyl related thyroid cancers. Br J Cancer. 2000. 01. 82:315–322.

36. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, et al. RET/PTC rearrangements in thyroid nodules : studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab. 2001. 07. 86:3211–3216.

37. Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, et al. Multiple endocrine neoplasia type 2 : evaluation of the genotype-phenotype relationship. Arch Surg. 2003. 04. 138:409–416. discussion 416.

TOOLS

Similar articles